On the other hand, nuclear HMGB1 plays a protective role in tumor suppression and tumor chemoradiotherapy and immunotherapy, reducing potential side effects occurring after systemic therapies that target not only tumoral cells but also actively replicating, healthy cells, such as the bone marrow, and basal layer-based cells [33]. The gene discussed is HMGB1; the disease is neoplasm.